Literature DB >> 1327980

Modulation of human upper intestinal nutrient transit by a beta adrenoreceptor mediated pathway.

A S McIntyre1, D G Thompson, S Day, W R Burnham, E R Walker.   

Abstract

To explore the role played by beta adrenoreceptor mediated pathways on human upper gut function a series of studies were conducted into the effects of beta adrenoreceptor agonists and antagonists on orocaecal and duodenocaecal transit and on antral and duodenal motor activity. Under control conditions orocaecal transit was consistent within individuals (mean coefficient of variation (18.0%) but varied widely between individuals (median transit 63 minutes, range 33-164). Prior administration of the non-selective beta adrenergic antagonist propranolol consistently hastened orocaecal transit (median transit 51:25-93, v control p < 0.005). The selective beta-1 antagonist, atenolol, also hastened transit (median transit 50:35-93 minutes, v control p < 0.01). The magnitude of an individual's response to beta blockade correlated closely with the orocaecal transit (Tau = 0.54, p < 0.01). Duodenocaecal transit was also hastened by propranolol from control values of 66:45-107 minutes to 50:16-62 minutes, p < 0.025). In contrast neither duodenal nor antral motility were consistently altered by beta blockade. The beta adrenoreceptor agonist, isoprenaline, delayed both orocaecal transient (97:55-178 minutes, v control p < 0.005) and also duodenocaecal transit (160:45-215 minutes, v 73:40-133) (p < 0.025). Isoprenaline also reduced antral motility by an effect which appeared to occur predominantly through a reduction in contraction amplitude (from a median amplitude of 27:5.39 mm Hg to 14:3-24 mm Hg, p < 0.03) rather than an effect on the interval between contractions. No effect on either amplitude or frequency of duodenal motor activity was observed. A beta adrenoreceptor mediated pathway thus appears to exert a biologically relevant effect on gut function not only under conditions of sympathetic stimulation, but also at rest when a basal beta adrenergic tone appears to influence the speed of nutrient transit through the human upper gut.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327980      PMCID: PMC1379443          DOI: 10.1136/gut.33.8.1062

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Andrenergic receptive mechanism of canine ileum.

Authors:  R P AHLQUIST; B LEVY
Journal:  J Pharmacol Exp Ther       Date:  1959-10       Impact factor: 4.030

2.  Mechanism of beta-adrenergic relaxation of smooth muscle.

Authors:  C R Scheid; T W Honeyman; F S Fay
Journal:  Nature       Date:  1979-01-04       Impact factor: 49.962

3.  Perturbation of upper gastrointestinal transit and antroduodenal motility by experimentally applied stress: the role of beta-adrenoreceptor mediated pathways.

Authors:  J D O'Brien; D G Thompson; S J Day; W R Burnham; E Walker
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

4.  The effects of sympathetic nerve stimulation and guanethidine on parasympathetic neuroeffector transmission; the inhibition of acetylcholine release.

Authors:  E S Vizi; J Knoll
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

5.  Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli.

Authors:  V Stanghellini; J R Malagelada; A R Zinsmeister; V L Go; P C Kao
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

6.  Evidence that blockade of adrenergic receptors causes overflow of norepinephrine in cats colon after nerve stimulation.

Authors:  D J Boullin; E Costa; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1967-07       Impact factor: 4.030

7.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

8.  Isoproterenol induces activity fronts in fed dogs through somatostatin release.

Authors:  R W Summers; A Flatt; R J Yanda; T Yamada
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

9.  Action of centrally mediated autonomic stimulation on human upper gastrointestinal transit: a comparative study of two stimuli.

Authors:  J D O'Brien; D G Thompson; W R Burnham; J Holly; E Walker
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

10.  Hypokalemia from beta2-receptor stimulation by circulating epinephrine.

Authors:  M J Brown; D C Brown; M B Murphy
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

View more
  13 in total

1.  Stimulation of beta-adrenoceptors with isoprenaline inhibits small intestinal activity fronts and induces a postprandial-like motility pattern in humans.

Authors:  M Thollander; T H Svensson; P M Hellström
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Cisapride reduces postoperative gastrocaecal transit time after cardiac surgery in children.

Authors:  L Bindl; S Buderus; M Ramirez; P Kirchhoff; M J Lentze
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

3.  Rapid distal small bowel transit associated with sympathetic denervation in type I diabetes mellitus.

Authors:  L Rosa-e-Silva; L E Troncon; R B Oliveira; M C Foss; F J Braga; L Gallo Júnior
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

4.  Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs.

Authors:  Gwen M C Masclee; Preciosa M Coloma; Ernst J Kuipers; Miriam C J M Sturkenboom
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

5.  Cirrhotic Patients Have Worse Bowel Preparation at Screening Colonoscopy than Chronic Liver Disease Patients without Cirrhosis.

Authors:  Anika K Anam; Kunal Karia; Arun B Jesudian; Brian P Bosworth
Journal:  J Clin Exp Hepatol       Date:  2016-08-31

6.  Beta adrenergic modulation of human upper intestinal propulsive forces.

Authors:  N K Ahluwalia; D G Thompson; J Barlow; L Heggie
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

7.  Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults.

Authors:  S D Mann; H S Debinski; M A Kamm
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

8.  5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake.

Authors:  D A Gorard; G W Libby; M J Farthing
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

9.  Determinants of accelerated small intestinal transit in alcohol-related chronic pancreatitis.

Authors:  Lucilene Rosa-E-Silva; Luiz E A Troncon; Lourenço Gallo; Milton C Foss; Afonso D C Passos; Gleici C Perdoná; Jorge A Achcar; Ricardo B Oliveira
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

10.  Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome.

Authors:  D A Gorard; G W Libby; M J Farthing
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.